Robotic preparation: Perspectives from the 1st European RIVA™ chemotherapy center
Known for 12 years in the North American market, the RIVA Automated Compounding System has prepared more than 12,5 million doses worldwide, and proven suitable for the preparation of chemotherapies.
The objective of this symposium is to enlighten hospital pharmacists and the staff of the pharmacy on the strengths of RIVA and how to choose the most appropriate way to use automated compounding. Some of the questions answered will include:
Does RIVA really meet all of the requirements including patient and staff safety, productivity and less technician time? How can RIVA strengthen the chemotherapy preparation of a hospital pharmacy for both standardized and patient-specific doses in a hospital center?